Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.39M | 2.27M | 1.73M | 1.69M | 1.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.39M | 2.27M | 1.73M | 1.69M | 1.95M |
| Cost of Revenue | 1.33M | 1.30M | 1.14M | 1.13M | 1.19M |
| Gross Profit | 1.07M | 971.30K | 591.20K | 554.50K | 752.90K |
| SG&A Expenses | 766.60K | 772.30K | 724.40K | 780.50K | 780.40K |
| Depreciation & Amortization | 700.00 | 1.10K | 2.30K | 5.40K | 6.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.14M | 2.08M | 1.87M | 1.92M | 2.01M |
| Operating Income | 251.60K | 191.00K | -135.70K | -232.20K | -63.20K |
| Income Before Tax | 250.20K | 241.00K | -134.60K | -225.90K | -63.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 250.20K | 241.00K | -134.60K | -225.90K | -63.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 250.20K | 241.00K | -134.60K | -225.90K | -63.60K |
| EBIT | 251.60K | 191.00K | -135.70K | -232.20K | -63.20K |
| EBITDA | 263.30K | 192.00K | -130.30K | -226.80K | 59.10K |
| EPS Basic | 0.02 | 0.02 | -0.01 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | 0.02 | 0.02 | -0.01 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 13.18M | 11.94M | 11.94M | 11.94M | 11.94M |
| Average Diluted Shares Outstanding | 13.55M | 12.78M | 11.94M | 11.94M | 11.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |